NO20080418L - Pyrido[2,3-D]pyrimidiriderivater, fremgangsmate for fremstilling derav og terapeutisk anvendelse av samme - Google Patents

Pyrido[2,3-D]pyrimidiriderivater, fremgangsmate for fremstilling derav og terapeutisk anvendelse av samme

Info

Publication number
NO20080418L
NO20080418L NO20080418A NO20080418A NO20080418L NO 20080418 L NO20080418 L NO 20080418L NO 20080418 A NO20080418 A NO 20080418A NO 20080418 A NO20080418 A NO 20080418A NO 20080418 L NO20080418 L NO 20080418L
Authority
NO
Norway
Prior art keywords
pyrido
derivatives
preparation
therapeutic use
pyrimidiride
Prior art date
Application number
NO20080418A
Other languages
English (en)
Norwegian (no)
Inventor
Pierre Perreaut
Bernard Bourrie
Samir Jegham
Pierre Casellas
Claude Muneaux
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20080418L publication Critical patent/NO20080418L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20080418A 2005-07-01 2008-01-22 Pyrido[2,3-D]pyrimidiriderivater, fremgangsmate for fremstilling derav og terapeutisk anvendelse av samme NO20080418L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0507032A FR2887882B1 (fr) 2005-07-01 2005-07-01 Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
PCT/FR2006/001518 WO2007003765A1 (fr) 2005-07-01 2006-06-29 DERIVES DE PYRIDO[2,3-d]PYRIMIDINE, LEUR PREPARATION, LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
NO20080418L true NO20080418L (no) 2008-03-28

Family

ID=36096420

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080418A NO20080418L (no) 2005-07-01 2008-01-22 Pyrido[2,3-D]pyrimidiriderivater, fremgangsmate for fremstilling derav og terapeutisk anvendelse av samme

Country Status (41)

Country Link
US (2) US7504406B2 (zh)
EP (2) EP2020410B1 (zh)
JP (1) JP4472009B2 (zh)
KR (1) KR101298344B1 (zh)
CN (2) CN102260258B (zh)
AR (1) AR054812A1 (zh)
AT (1) ATE423119T1 (zh)
AU (1) AU2006264801B2 (zh)
BR (1) BRPI0613020A2 (zh)
CA (1) CA2610794C (zh)
CR (1) CR9568A (zh)
CY (2) CY1110457T1 (zh)
DE (1) DE602006005246D1 (zh)
DK (2) DK1902054T3 (zh)
DO (1) DOP2006000145A (zh)
EA (1) EA014312B1 (zh)
EC (1) ECSP078011A (zh)
ES (2) ES2450067T3 (zh)
FR (1) FR2887882B1 (zh)
HK (1) HK1122797A1 (zh)
HR (2) HRP20090236T1 (zh)
IL (1) IL187900A0 (zh)
JO (1) JO2550B1 (zh)
MA (1) MA29561B1 (zh)
ME (1) ME01813B (zh)
MX (1) MX2007016239A (zh)
MY (1) MY143089A (zh)
NO (1) NO20080418L (zh)
NZ (1) NZ564072A (zh)
PA (1) PA8684801A1 (zh)
PE (1) PE20070139A1 (zh)
PL (2) PL1902054T3 (zh)
PT (2) PT2020410E (zh)
RS (2) RS50781B (zh)
SI (2) SI2020410T1 (zh)
TN (1) TNSN07440A1 (zh)
TW (1) TWI321566B (zh)
UA (1) UA92021C2 (zh)
UY (1) UY29645A1 (zh)
WO (1) WO2007003765A1 (zh)
ZA (1) ZA200711032B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
FR2910813B1 (fr) * 2006-12-28 2009-02-06 Sanofi Aventis Sa Nouvelle utilisation therapeutique pour le traitement des leucemies
AU2009304596A1 (en) 2008-10-17 2010-04-22 Akaal Pharma Pty Ltd S1P receptors modulators
AU2009304598B2 (en) * 2008-10-17 2015-01-29 Akaal Pharma Pty Ltd S1P receptors modulators and their use thereof
FR2948568B1 (fr) * 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
CN103204822B (zh) 2012-01-17 2014-12-03 上海科州药物研发有限公司 作为蛋白激酶抑制剂的苯并噁唑化合物及其制备方法和用途
EP2638911A1 (en) 2012-03-14 2013-09-18 Sanofi Novel combinations for treating acute myeloid leukaemia or chronic myeloid leukaemia
CN103833771A (zh) * 2012-11-22 2014-06-04 天津滨江药物研发有限公司 作为蛋白激酶Mek抑制剂的苯并五元杂环化合物及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171218A (en) * 1967-11-09 1969-11-19 Parke Davis & Co New Heterocyclic Amine Compounds and Methods for their Production
JPH04128276A (ja) 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途
GEP20012444B (en) * 1994-11-14 2001-05-25 Warner Lambert Company Us 6-Aryl Pyrido[2,3-d]Pyrimidines and Naphthyridines, Pharmaceutical Composition on Their Basis and Application for Inhibiting Cellular Proliferation
IL115256A0 (en) 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
US5620981A (en) * 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
AR030044A1 (es) * 2000-01-25 2003-08-13 Warner Lambert Co Pirido (2,3-d ) pirimidin-2,7-diaminas inhibidores de quinasas
OA12227A (en) * 2000-03-06 2004-03-18 Warner Lambert Co 5-AlkylpyridoÄ2,3-DÜpyrimidines tyrosine kinase inhibitors.
DE60135854D1 (de) 2000-08-04 2008-10-30 Warner Lambert Co 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-one
AU2002324450A1 (en) * 2001-06-21 2003-01-08 Ariad Pharmaceuticals, Inc. Novel pyridopyrimidines and uses thereof
AU2002952453A0 (en) * 2002-11-01 2002-11-21 Novogen Research Pty Ltd Aminated isoflavonoid derivatives and uses thereof
WO2004063195A1 (en) 2003-01-03 2004-07-29 Sloan-Kettering Institute For Cancer Research Pyridopyrimidine kinase inhibitors
TW200502236A (en) * 2003-03-28 2005-01-16 Hoffmann La Roche Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
WO2005105097A2 (en) 2004-04-28 2005-11-10 Gpc Biotech Ag Pyridopyrimidines for treating inflammatory and other diseases
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
US8338435B2 (en) * 2006-07-20 2012-12-25 Gilead Sciences, Inc. Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections

Also Published As

Publication number Publication date
CY1114989T1 (el) 2016-12-14
CN101213196A (zh) 2008-07-02
JO2550B1 (en) 2010-09-05
US20080176874A1 (en) 2008-07-24
JP4472009B2 (ja) 2010-06-02
NZ564072A (en) 2012-02-24
AR054812A1 (es) 2007-07-18
TWI321566B (en) 2010-03-11
EP2020410B1 (fr) 2013-12-18
EP1902054B1 (fr) 2009-02-18
PA8684801A1 (es) 2007-01-17
AU2006264801B2 (en) 2012-05-10
PT2020410E (pt) 2014-03-20
HK1122797A1 (en) 2009-05-29
ECSP078011A (es) 2008-01-23
RS50781B (sr) 2010-08-31
ES2322101T3 (es) 2009-06-16
KR101298344B1 (ko) 2013-08-20
TNSN07440A1 (en) 2009-03-17
CA2610794C (fr) 2012-02-21
DE602006005246D1 (de) 2009-04-02
HRP20140246T1 (hr) 2014-06-20
CA2610794A1 (fr) 2007-01-11
PT1902054E (pt) 2009-04-22
JP2008544975A (ja) 2008-12-11
IL187900A0 (en) 2008-03-20
MX2007016239A (es) 2008-03-06
HRP20090236T1 (en) 2009-05-31
UY29645A1 (es) 2007-01-31
TW200745102A (en) 2007-12-16
EA200800223A1 (ru) 2008-06-30
WO2007003765A1 (fr) 2007-01-11
KR20080021714A (ko) 2008-03-07
PL1902054T3 (pl) 2009-07-31
CR9568A (es) 2008-02-20
DOP2006000145A (es) 2008-01-31
AU2006264801A1 (en) 2007-01-11
ES2450067T3 (es) 2014-03-21
CN101213196B (zh) 2011-09-07
FR2887882A1 (fr) 2007-01-05
CY1110457T1 (el) 2015-04-29
US7504406B2 (en) 2009-03-17
FR2887882B1 (fr) 2007-09-07
US8008310B2 (en) 2011-08-30
ME01813B (me) 2014-09-20
RS53211B (en) 2014-08-29
MY143089A (en) 2011-03-15
US20090163522A1 (en) 2009-06-25
EP1902054A1 (fr) 2008-03-26
UA92021C2 (ru) 2010-09-27
ATE423119T1 (de) 2009-03-15
CN102260258A (zh) 2011-11-30
EA014312B1 (ru) 2010-10-29
ZA200711032B (en) 2009-04-29
MA29561B1 (fr) 2008-06-02
DK1902054T3 (da) 2009-06-15
SI1902054T1 (sl) 2009-06-30
PE20070139A1 (es) 2007-03-07
BRPI0613020A2 (pt) 2010-12-14
PL2020410T3 (pl) 2014-05-30
EP2020410A1 (fr) 2009-02-04
SI2020410T1 (sl) 2014-04-30
DK2020410T3 (en) 2014-03-24
CN102260258B (zh) 2015-01-07

Similar Documents

Publication Publication Date Title
NO20080418L (no) Pyrido[2,3-D]pyrimidiriderivater, fremgangsmate for fremstilling derav og terapeutisk anvendelse av samme
MX2011012353A (es) Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2, 3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como inhibidores de la cinasa janus.
MX2009010728A (es) Compuestos de imidazo[1,2-a]piridina como inhibidores de la tirosina-cinasa repectora.
NO20064000L (no) Heteroarylkoblede pyrazoloderivater
NO20075232L (no) Fremgangsmate for fremstilling av pyrido[2,3-d]pyrimidin-7-on og 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1 H)-on derivater
WO2008121687A3 (en) Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
NO20074964L (no) Pyrimidinderivater for behandling av hyperproliferative forstyrrelser
MX2009006863A (es) Inhibidores novedosos de c-jun-n-terminal cinasas.
SG179430A1 (en) Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
GB0305929D0 (en) Organic compounds
MX2010006748A (es) Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2.
ZA200707901B (en) Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
ME00230B (me) 2-(piridin -2-ilamino)-pirido(2,3-d) pirimidin-7-oni
WO2006065590A3 (en) Pyridine and pyrimidine antiviral compositions
EP1633740A4 (en) CHEMICAL COMPOUNDS
UA92503C2 (ru) Соединения 5-(фенилизоксазолилэтокси)-триазол-3-ил-замещенного пиридина для лечения неврологических, психиатрических или болевых расстройств
NO20081349L (no) Pyrrolopyrimidinderivater som Syk-inhibitorer
RS105204A (en) Substituted 3-amino-thieno/2,3-b/pyridine- 2-carboxylic acid amide compounds and processes for preparing and their uses
ATE424402T1 (de) Imidazopyridinverbindungen
NO20054208L (no) Nitrogen-substituerte heksahydropyrazino[1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
TNSN07323A1 (en) Imidazo (1, 2-a) pyridine compounds as vegf-r2 inhibitors
TW200630374A (en) Thiazolyldihydroindazoles
TW200606162A (en) Pyrazolopyridine derivatives
WO2007058832A3 (en) Pyrrolo (2, 3-b) pyridine derivatives useful as tec kinase inhibitors
MY150747A (en) Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application